Begrivac

Country: Nýja-Sjáland

Tungumál: enska

Heimild: Medsafe (Medicines Safety Authority)

Virkt innihaldsefni:

Influenza virus haemagglutinin type A/Moscow/10/99 H3N2 - like strain 15ug; Influenza virus haemagglutinin type A/New Caledonia/20/99 H1N1-like strain 15ug; Influenza virus haemagglutinin type B/Sichuan/379/99 - like strain 15ug

Fáanlegur frá:

Novartis New Zealand Ltd

INN (Alþjóðlegt nafn):

Influenza virus haemagglutinin type A/Moscow/10/99 H3N2 - like strain 15 µg

Skammtar:

0.5 mL

Lyfjaform:

Suspension for injection

Samsetning:

Active: Influenza virus haemagglutinin type A/Moscow/10/99 H3N2 - like strain 15ug Influenza virus haemagglutinin type A/New Caledonia/20/99 H1N1-like strain 15ug Influenza virus haemagglutinin type B/Sichuan/379/99 - like strain 15ug Excipient: Ether Formaldehyde Phosphate Buffered Saline Polymyxin B Polysorbate 80 Sucrose

Einingar í pakka:

Syringe, glass, Prefilled single 0.5ml dose, 1 dose unit

Tegund:

Prescription

Gerð lyfseðils:

Prescription

Framleitt af:

GSK Vaccines GmbH

Vörulýsing:

Package - Contents - Shelf Life: Syringe, glass, Prefilled single 0.5ml dose - 1 dose units - 12 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) - Syringe, glass, 0.5mL syringe, 10 pack - 10 dose units - 12 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze)

Leyfisdagur:

1999-11-12